AlphaYou
Overview
Smart money at a glance
Filings to Oct 10, 2026Net selling: insiders sold $103K and bought $0 on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
- Company insidersSEC Form 4, last 90 days
- -$103K netNet selling
- CongressSTOCK Act, last 180 days
- NoneNo trades disclosed
- Big fundsSEC 13F, latest quarter
- NoneNo large changes
Market overview
Fundamentals Oct 9- Open
- $4.89
- 52-wk high
- $34.40
- High
- $4.92
- 52-wk low
- $4.72
- Low
- $4.72
- Prev close
- $4.91
- Mkt cap
- $28.1M
- Volume
- 28.0K
- Beta
- 1.15
- P/S
- 19.3x
- Profit margin
- +0.0%
- Op margin
- -774.0%
- ROE
- +0.0%
What do analysts expect?
No analyst estimates.
Questions about ONMD filings
Are insiders buying or selling OneMedNet Corp. (ONMD) stock?
Net selling: insiders sold $103K and bought $0 of ONMD stock on the open market in the 90 days to Oct 10, 2026, according to SEC Form 4 filings. The largest was Golden, Robert Lawrence (Chief Financial Officer), who sold $55K. The latest filing was on Oct 10, 2026.
Which members of Congress have traded ONMD recently?
None. No member of Congress disclosed a ONMD trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.
How current is this ONMD smart-money data?
This summary uses filings available on Oct 10, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
3 funds hold a position and insiders have been net buying.
What insiders are doing
How top traders are positioned
No tracked top-trader positions in ONMD right now.
Live Hyperliquid positioning - not every stock is covered
Earnings
Results versus expectations
No reported figure for the latest quarter.
Company release linked above, where available
Previous reports
All values in USD| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / estimate | Rev. surprise |
|---|---|---|---|---|---|
| Jun 30, 2026 | Aug 12, 2026 | Unavailable | - | Unavailable | Unavailable |
| Mar 31, 2026 | May 15, 2026 | Unavailable | - | Unavailable | Unavailable |
| Dec 31, 2025 | Mar 30, 2026 | Unavailable | - | Unavailable | Unavailable |
| Sep 30, 2025 | Nov 14, 2025 | Unavailable | - | Unavailable | Unavailable |
| Jun 30, 2025 | Aug 13, 2025 | Unavailable | - | Unavailable | Unavailable |
| Mar 31, 2025 | Apr 15, 2025 | Unavailable | - | Unavailable | Unavailable |
| Dec 31, 2024 | Dec 31, 2024 | Unavailable | - | Unavailable | Unavailable |
| Sep 30, 2024 | Dec 5, 2024 | Unavailable | - | Unavailable | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue uses company releases and saved estimates.
Reports Nov 13, 2026, in 34 days
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $177.0K | $891.0K | $96.0K | $292.0K |
| Cost of what it sold | $399.0K | $726.0K | $476.0K | $857.0K |
| Gross profit | -$222.0K | $165.0K | -$380.0K | -$565.0K |
| What it spent | ||||
| Research and development | $323.0K | $443.0K | $311.0K | $324.0K |
| Sales and admin | $1.4M | $2.4M | $1.5M | $981.0K |
| Other operating costs | $304.0K | $426.0K | $378.0K | $391.0K |
| Total operating expenses | $2.0M | $3.2M | $2.2M | $1.7M |
| What was left | ||||
| Operating profit | -$2.2M | -$3.1M | -$2.6M | -$2.3M |
| Interest on debt | $6.0K | $8.0K | $10.0K | $9.0K |
| Profit before tax | -$741.0K | -$3.1M | -$2.5M | -$2.2M |
| Tax | — | $1.0K | — | — |
| Net profit | -$741.0K | -$3.1M | -$2.5M | -$2.2M |
| EBITDA | -$725.0K | -$3.1M | -$2.4M | -$2.3M |
Technicals
Price structure
This stock is under pressure, and looks oversold after a sharp drop.
Trend
Under pressure
0 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace